SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-026049
Filing Date
2023-04-28
Accepted
2023-04-28 16:34:05
Documents
1
Period of Report
2023-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3785
  Complete submission text file 0001209191-23-026049.txt   5300
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LUX CAPITAL MANAGEMENT, LLC 1600 EL CAMINO REAL - SUITE 290 MENLO PARK CA 94025
Business Address
Dar Zavain (Reporting) CIK: 0001852075 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40323 | Film No.: 23867165